OrganiGram Holdings Inc
TSX:OGI
OrganiGram Holdings Inc
TSX:OGI
Price:
2.05
CAD
5.13%
Market Cap:
CA$275.4m
Relative Value
The Relative Value of one
OGI
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 2.05 CAD,
OrganiGram Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OGI Relative Value
HIDDEN
Multiples Across Competitors
OGI Competitors Multiples
OrganiGram Holdings Inc Competitors
OrganiGram Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
OrganiGram Holdings Inc
TSX:OGI
|
277m CAD | 1 | 15.2 | -4.8 | -3.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
928.8B USD | 14.3 | 45 | 30.4 | 32.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.7B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
254.8B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.3B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.7B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.6B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.9B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
